Long-Term Temozolomide in Patients With Glioblastoma Long-Term Temozolomide in Patients With Glioblastoma
Temozolomide maintenance therapy looks promising in glioblastoma, but with caveats.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2022 Category: Cancer & Oncology Tags: Neurology & Neurosurgery News Source Type: news

Long-term Opioid Use a Risk Factor for Cancer Long-term Opioid Use a Risk Factor for Cancer
People who took opioids long-term had a higher incidence of cancer than those who did not take the pain relievers, according to a population-based cohort study.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Preop Nivolumab Plus Chemo'a Quantum Leap' in NSCLC Therapy Preop Nivolumab Plus Chemo'a Quantum Leap' in NSCLC Therapy
Further data from the pivotal Checkmate 816 trial continue to support the combination of nivolumab with chemotherapy in the neoadjuvant setting for patients with resectable non –small cell lung cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Convincing Patients That You Can't'Starve' Cancer Convincing Patients That You Can't'Starve' Cancer
The notion that you can starve a tumor is one of the most pervasive misconceptions among cancer patients.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

With or Without Children: It Is None of Your Business With or Without Children: It Is None of Your Business
As a physician in my thirties, people assume I have children -- or even worse, negatively judge me for not. What do I tell them? Why have I chosen this path? Find out why it really is nobody ' s business.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

PLA Test Brings Nuance to the Diagnosis of Early-Stage Melanoma PLA Test Brings Nuance to the Diagnosis of Early-Stage Melanoma
Prospective randomized clinical trials are needed"to examine the role of genetic expression profiling in staging and managing patients," according to Caroline Kim, MD.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2022 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Mutation Testing in Advanced Thyroid Cancer Mutation Testing in Advanced Thyroid Cancer
All patients with advanced thyroid disease and most patients with incurable radioiodine refractory differentiated thyroid cancer should undergo somatic mutational testing, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Can Cancer Blood Tests Live Up to Promise of Saving Lives? Can Cancer Blood Tests Live Up to Promise of Saving Lives?
The Canby, Oregon, resident had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people.Associated Press (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Weighing the Complexity of Pathologic Response in Lung Cancer Weighing the Complexity of Pathologic Response in Lung Cancer
Pathologic response has emerged as a valuable endpoint and surrogate marker for overall survival in lung cancer studies, but much work remains to be done.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breakthrough COVID Dangerous for Vaccinated Patients With Cancer Breakthrough COVID Dangerous for Vaccinated Patients With Cancer
Vaccinated patients with cancer are more likely than those without cancer to contract a breakthrough COVID-19 infection, which puts them at a much higher risk for hospitalization and death.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

More Drugs Tested in Pediatric Cancer: RACE for Children Act More Drugs Tested in Pediatric Cancer: RACE for Children Act
What has been the impact of the Research to Accelerate Cures and Equity (RACE) for Children Act, introduced to support the study of drugs for pediatric cancers?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Truly Impressive' Responses in Lymphoma With Novel Cell Therapy'Truly Impressive' Responses in Lymphoma With Novel Cell Therapy
Activated natural killer cells combined with a bispecific antibody showed strong activity in heavily pretreated patients with lymphoma expressing the CD30 antigen.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Recurrent DCIS Can Be Genetically Distinct From Primary Lesion Recurrent DCIS Can Be Genetically Distinct From Primary Lesion
In more than 10% of cases, when ductal carcinoma in situ recurs in the same breast, the new lesion is genetically district from the original lesion.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Living in Fear of Cancer Recurrence —Some May Need Help Living in Fear of Cancer Recurrence —Some May Need Help
Over half of cancer survivors as well as those with active cancer report at least a moderate level of fear, but about 20% report a high level of fear and may need specialized help.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Real-World' Increase in Biomarker Testing in NSCLC'Real-World' Increase in Biomarker Testing in NSCLC
Real-world data from Spain suggest that biomarker testing for patients with advanced non –small cell lung cancer (NSCLC) is finally increasing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news